应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03347 泰格医药
未开盘 03-26 16:08:17
39.340
-0.480
-1.21%
最高
41.480
最低
38.780
成交量
160.83万
今开
39.820
昨收
39.820
日振幅
6.78%
总市值
338.72亿
流通市值
48.44亿
总股本
8.61亿
成交额
6,406万
换手率
1.31%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股生物医药板块涨幅居前,康方生物涨超5%,科伦博泰生物涨超4%
老虎资讯综合 · 03-26 09:54
港股生物医药板块涨幅居前,康方生物涨超5%,科伦博泰生物涨超4%
泰格医药(300347)披露董事会会议召开日期公告,3月18日股价上涨0.08%
证券之星 · 03-18
泰格医药(300347)披露董事会会议召开日期公告,3月18日股价上涨0.08%
股市必读:3月13日泰格医药现220.44万元大宗交易
证券之星 · 03-16
股市必读:3月13日泰格医药现220.44万元大宗交易
3月13日泰格医药现220.44万元大宗交易
证券之星 · 03-13
3月13日泰格医药现220.44万元大宗交易
泰格医药03月11日主力净流出227.3万元 散户资金买入
市场透视 · 03-11
泰格医药03月11日主力净流出227.3万元 散户资金买入
每日卖空追踪 | 泰格医药 03月10日卖空量成交8.56万股,卖空比例为4.32%
市场透视 · 03-10
每日卖空追踪 | 泰格医药 03月10日卖空量成交8.56万股,卖空比例为4.32%
泰格医药盘中异动 早盘股价大涨5.49%报44.580港元
市场透视 · 03-10
泰格医药盘中异动 早盘股价大涨5.49%报44.580港元
泰格医药盘中异动 股价大跌5.57%报41.700港元
市场透视 · 03-09
泰格医药盘中异动 股价大跌5.57%报41.700港元
每日卖空追踪 | 泰格医药 03月06日卖空量成交4.95万股,卖空比例为6.05%
市场透视 · 03-06
每日卖空追踪 | 泰格医药 03月06日卖空量成交4.95万股,卖空比例为6.05%
方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局
全景网 · 03-06
方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局
泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%
证券之星 · 03-05
泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%
泰格医药(03347)2026年2月股份变动月报表,股本保持稳定
公告速递 · 03-05
泰格医药(03347)2026年2月股份变动月报表,股本保持稳定
大和:升泰格医药(03347)目标价至45港元 上调收入预测
智通财经 · 03-04
大和:升泰格医药(03347)目标价至45港元 上调收入预测
CRO龙头,2.7亿内部大洗牌
药圈观察局 · 03-03
CRO龙头,2.7亿内部大洗牌
泰格医药(03347)完成出售上海观合医药全部已发行股本
智通财经 · 03-03
泰格医药(03347)完成出售上海观合医药全部已发行股本
每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%
市场透视 · 03-03
每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%
泰格医药盘中异动 下午盘股价大跌5.00%
市场透视 · 03-03
泰格医药盘中异动 下午盘股价大跌5.00%
《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测
AASTOCKS · 03-03
《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测
医药行业周报:哮喘与COPD:长效化、生物药加速突破
中信建投证券 · 03-01
医药行业周报:哮喘与COPD:长效化、生物药加速突破
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
市场透视 · 02-27
每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%
加载更多
公司概况
公司名称:
泰格医药
所属市场:
SEHK
上市日期:
--
主营业务:
杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":39.34,"timestamp":1774512497006,"preClose":39.82,"halted":0,"volume":1608300,"delay":0,"changeRate":-0.012054244098442916,"floatShares":123124800,"shares":861000000,"eps":0.5311408366773613,"marketStatus":"未开盘","change":-0.48,"latestTime":"03-26 16:08:17","open":39.82,"high":41.48,"low":38.78,"amount":64057934,"amplitude":0.067805,"askPrice":39.34,"askSize":2400,"bidPrice":39.32,"bidSize":800,"shortable":3,"etf":0,"ttmEps":0.8080307686047422,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774575000000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":39.82,"dividendRate":0.008636,"openAndCloseTimeList":[[1774488600000,1774497600000],[1774501200000,1774512000000]],"volumeRatio":0.982094769140536,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":50.78,"timestamp":1774508400000,"preClose":50.48,"halted":0,"volume":10309200,"delay":0,"premium":"-31.53"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"1112843274","title":"港股生物医药板块涨幅居前,康方生物涨超5%,科伦博泰生物涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112843274","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112843274?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:54","pubTimestamp":1774490076,"startTime":"0","endTime":"0","summary":"3月26日,$生物(000504)$医药板块涨幅居前,$康方生物(09926)$涨超5%,$科伦博泰(06990)$生物涨超4%,$泰格医药(03347)$、$荣昌生物(09995)$涨超3%,$药明康德(02359)$、$君实生物(01877)$等个股跟涨","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","LU0348784397.USD","LU1961090484.USD","LU0348766576.USD","09926","02162","09995","BK4588","BK4581","LU2778985437.USD","LU1720050803.USD","01877","LU2476274308.USD","IE00B5MMRT66.SGD","BK1161","IE00BPRC5H50.USD","BK1574","LU0348783233.USD","LU0540923850.HKD","LU0348767384.USD","LU0417516738.SGD","BK4585","LU0634319403.HKD","LU2476274720.SGD","LU0348735423.USD","LU0561508036.HKD","LU2488822045.USD","LU2399975544.HKD","LU1794554557.SGD","LU0348827113.USD","IE00B543WZ88.USD","LU0348825331.USD","LU0417516571.SGD","03347"],"gpt_icon":0},{"id":"2620825262","title":"泰格医药(300347)披露董事会会议召开日期公告,3月18日股价上涨0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620825262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620825262?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:27","pubTimestamp":1773844036,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘,泰格医药报收于52.99元,较前一交易日上涨0.08%,最新总市值为456.26亿元。该股当日开盘52.98元,最高53.15元,最低52.3元,成交额达4.06亿元,换手率为1.36%。近日,杭州泰格医药科技股份有限公司发布H股公告,宣布将于2026年3月30日举行董事会会议,审议及批准公司及其附属公司截至2025年12月31日止年度的全年业绩及其刊发,并考虑建议派发末期股息(如适用)。公告发布日期为2026年3月18日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","300347","BK0077","03347","LU1146622755.USD","BK0174","BK1583","BK0028","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2619884483","title":"股市必读:3月13日泰格医药现220.44万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2619884483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619884483?lang=zh_cn&edition=full","pubTime":"2026-03-16 03:36","pubTimestamp":1773603373,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,泰格医药报收于55.11元,下跌1.25%,换手率1.91%,成交量10.84万手,成交额5.99亿元。当日关注点来自交易信息汇总:3月13日主力资金净流入40.38万元,散户资金积极进场,游资呈明显流出态势。来自交易信息汇总:当日发生220.44万元大宗交易,反映个股存在特定机构或大额交易动向。大宗交易3月13日泰格医药现220.44万元大宗交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","03347","BK0028","BK1583","LU1820825898.SGD","BK1576","BK0216","300347","BK0077","BK0174","BK1141"],"gpt_icon":0},{"id":"2619957160","title":"3月13日泰格医药现220.44万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2619957160","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619957160?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:11","pubTimestamp":1773393118,"startTime":"0","endTime":"0","summary":"证券之星消息,3月13日泰格医药发生大宗交易,交易数据如下:大宗交易成交价格55.11元,成交4万股,成交金额220.44万元,买方营业部为机构专用,卖方营业部为机构专用。近三个月该股共发生1笔大宗交易,合计成交400.0手。该股近期无解禁股上市。截至2026年3月13日收盘,泰格医药报收于55.11元,下跌1.25%,换手率1.91%,成交量10.84万手,成交额5.99亿元。该股最近90天内共有6家机构给出评级,买入评级6家;过去90天内机构目标均价为77.88。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300028929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","LU1820825898.SGD","BK0077","300347","BK0216","BK1576","BK0028","BK1583","BK0174","BK1141","LU1146622755.USD"],"gpt_icon":0},{"id":"2618920785","title":"泰格医药03月11日主力净流出227.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618920785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618920785?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216962,"startTime":"0","endTime":"0","summary":"03月11日, 泰格医药股价跌1.69%,报收43.16元,成交金额4199.3万元,换手率0.79%,振幅3.05%,量比0.56。泰格医药今日主力资金净流出227.3万元,上一交易日主力净流入287.1万元。该股近5个交易日上涨1.93%,主力资金累计净流入1232.1万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入3596.6万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162142a6b78af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162142a6b78af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","03347","BK1141"],"gpt_icon":0},{"id":"2618822951","title":"每日卖空追踪 | 泰格医药 03月10日卖空量成交8.56万股,卖空比例为4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618822951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618822951?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131434,"startTime":"0","endTime":"0","summary":"泰格医药北京时间03月10日,涨3.88%,卖空量成交8.56万股,较上一交易日减少91.5%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163446a45df8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163446a45df8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","BK1141","03347"],"gpt_icon":0},{"id":"2618951363","title":"泰格医药盘中异动 早盘股价大涨5.49%报44.580港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618951363?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:40","pubTimestamp":1773106816,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时40分,泰格医药股票出现波动,股价快速上涨5.49%。截至发稿,该股报44.580港元/股,成交量30.4万股,换手率0.25%,振幅4.12%。资金方面,该股资金流入905.184万港元,流出292.127万港元。最近的财报数据显示,该股实现营业收入55.05亿港元,净利润11.18亿港元,每股收益1.30港元,毛利16.05亿港元,市盈率87.74倍。泰格医药股票所在的生物技术行业中,整体涨幅为1.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310094016a45ce9fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310094016a45ce9fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","03347","BK1576"],"gpt_icon":0},{"id":"2618154966","title":"泰格医药盘中异动 股价大跌5.57%报41.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618154966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618154966?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:30","pubTimestamp":1773019804,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时30分,泰格医药股票出现异动,股价快速下挫5.57%。截至发稿,该股报41.700港元/股,成交量2.89万股,换手率0.02%,振幅1.45%。资金方面,该股资金流入35.445万港元,流出68.829万港元。最近的财报数据显示,该股实现营业收入55.05亿港元,净利润11.18亿港元,每股收益1.30港元,毛利16.05亿港元,市盈率82.07倍。泰格医药股票所在的生物技术行业中,整体跌幅为1.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093004a459a017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093004a459a017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1576","BK1583","BK1141"],"gpt_icon":0},{"id":"2617963207","title":"每日卖空追踪 | 泰格医药 03月06日卖空量成交4.95万股,卖空比例为6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617963207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617963207?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785834,"startTime":"0","endTime":"0","summary":"泰格医药北京时间03月06日,涨1.47%,卖空量成交4.95万股,较上一交易日减少72.45%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163451a6aa3ee7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163451a6aa3ee7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","03347","BK1576","BK1141"],"gpt_icon":0},{"id":"2617632075","title":"方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632075","media":"全景网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632075?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:00","pubTimestamp":1772766000,"startTime":"0","endTime":"0","summary":"2026年3月3日,泰格医药集团旗下方达控股宣布已正式完成对观合医药的收购。此次收购将进一步完善方达在全球中心实验室领域的布局,强化其在中国及亚太地区的综合服务能力。此次收购也是方达控股持续推进全球化布局的重要举措。方达控股始终坚守“全球同一质量体系”的准则,获得的试验数据支持多国申报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306110153a6a9213c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1576","BK1141","BK1583","BK1574","09939","01521","03347"],"gpt_icon":0},{"id":"2617523220","title":"泰格医药(300347)发布2026年第一次临时股东会决议公告,3月5日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617523220","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617523220?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:17","pubTimestamp":1772720236,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘,泰格医药报收于56.77元,较前一交易日上涨1.27%,最新总市值为488.8亿元。公司于近日发布《2026年第一次临时股东会决议的公告》。公告显示,杭州泰格医药科技股份有限公司于2026年3月5日召开2026年第一次临时股东会,会议采用现场与网络投票相结合方式,审议通过《关于变更公司注册地址及修订<公司章程>的议案》。A股及H股股东合计457人出席,代表有表决权股份431,255,969股,占公司有表决权股份总数的50.4309%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500039411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","LU1820825898.SGD","BK0174","BK0077","BK0028","300347","BK1583","BK0216","BK1576","BK1141","LU1146622755.USD"],"gpt_icon":0},{"id":"1181886244","title":"泰格医药(03347)2026年2月股份变动月报表,股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1181886244","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181886244?lang=zh_cn&edition=full","pubTime":"2026-03-05 16:47","pubTimestamp":1772700474,"startTime":"0","endTime":"0","summary":"2026年3月5日,泰格医药公布截至2026年2月28日的股份变动月报表。报告显示,公司A股与H股的法定股本均维持不变,A股法定股本为737,901,250股,每股面值人民币1元;H股法定股本为123,124,800股,每股面值人民币1元,总计人民币861,026,050元。根据公告,期内已发行A股总数为732,017,470股,另有5,883,780股A股被公司以库存股份形式持有,已发行H股总数为123,124,800股,均无新增发行或注销情况。截至2026年2月末,整体股本结构保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"gpt_icon":0},{"id":"2616304292","title":"大和:升泰格医药(03347)目标价至45港元 上调收入预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2616304292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616304292?lang=zh_cn&edition=full","pubTime":"2026-03-04 10:18","pubTimestamp":1772590731,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,大和发布研报称,上调对泰格医药的2026至2027年收入预测1%至7%,但下调同期每股盈利预测8%至12%,因调低毛利率并上调销售、行政开支及研发开支。维持“持有”评级,目标价由38港元升至45港元。泰格医药发盈喜,预期2025年收入同比增长1%至16%,至66.6亿至76.8亿元人民币(下同),在2024年跌11%后重拾增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347"],"gpt_icon":0},{"id":"2616326567","title":"CRO龙头,2.7亿内部大洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326567","media":"药圈观察局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326567?lang=zh_cn&edition=full","pubTime":"2026-03-03 20:42","pubTimestamp":1772541743,"startTime":"0","endTime":"0","summary":"药圈观察局,最新观察:本文为共创内容,作者:#药圈观察局1组据悉,临床CRO龙头泰格医药其历时近五个月的内部资产重组正式落定。泰格医药以2.7亿元人民币的对价,将旗下临床实验服务公司上海观合医药的全部股权,出售给同属集团旗下的子公司方达医药。泰格医药2025全年预计实现归属净利润8.3亿元至12.3亿元,比上年同期增长105%至204%。但同时,2025年7月,泰格医药又通过日本子公司收购了日本MICRON公司56.37%的股权,以加强其海外布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030321211997a7dc66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030321211997a7dc66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1141","03347","BK1515","BK1583","BK1161","BK1576","BK1574"],"gpt_icon":0},{"id":"2616349415","title":"泰格医药(03347)完成出售上海观合医药全部已发行股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2616349415","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616349415?lang=zh_cn&edition=full","pubTime":"2026-03-03 19:05","pubTimestamp":1772535909,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,有关出售上海观合医药科技股份有限公司(目标公司)的全部已发行股本相关事宜。股份转让协议中所载的所有先决条件均已获达成,而出售事项于2026年3月3日根据股份转让协议的条款及条件完成。于完成出售事项后,目标公司及其子公司(统称“目标集团”)将仍作为本公司的子公司。目标集团的财务业绩将并入方达集团的财务报表。由于出售事项属于本集团内部交易,出售事项不会对本集团的综合财务状况表产生任何重大影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1515","BK1576","BK1141","BK1583","BK0174","300347","LU1146622755.USD","BK1574","BK0028","159938","09939","BK0216","LU1820825898.SGD","03347","BK0077"],"gpt_icon":0},{"id":"2616326541","title":"每日卖空追踪 | 泰格医药 03月03日卖空量成交20.81万股,卖空比例为8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326541?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526636,"startTime":"0","endTime":"0","summary":"泰格医药北京时间03月03日,跌5.79%,卖空量成交20.81万股,较上一交易日减少27.06%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163459a69cace2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163459a69cace2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1576","BK1583","BK1141"],"gpt_icon":0},{"id":"2616326683","title":"泰格医药盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326683?lang=zh_cn&edition=full","pubTime":"2026-03-03 14:20","pubTimestamp":1772518815,"startTime":"0","endTime":"0","summary":"2026年03月03日下午盘14时20分,泰格医药股票出现异动,股价急速下跌5.00%。截至发稿,该股报43.680港元/股,成交量96.0932万股,换手率0.78%,振幅7.00%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,25%的券商给予持有建议,25%的券商给予卖出建议。泰格医药股票所在的生物技术行业中,整体跌幅为3.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030314201597a7c9e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030314201597a7c9e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","BK1141","03347"],"gpt_icon":0},{"id":"2616326592","title":"《大行》大和升泰格医药目标价至45元续吁“持有” 上调收入预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2616326592","media":"AASTOCKS","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616326592?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:56","pubTimestamp":1772502964,"startTime":"0","endTime":"0","summary":"大和研究报告指,泰格医药发盈喜,预期2025年收入按年增长1%至16%,至66.6亿至76.8亿元人民币(下同),在2024年跌11%后重拾增长。该行上调对泰格医药的2026至2027年收入预测1%至7%,但下调同期每股盈利预测8%至12%,因调低毛利率并上调销售、行政开支及研发开支。维持“持有”评级,目标价由38港元升至45港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101648a44455f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303101648a44455f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347"],"gpt_icon":0},{"id":"2616826552","title":"医药行业周报:哮喘与COPD:长效化、生物药加速突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826552","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826552?lang=zh_cn&edition=full","pubTime":"2026-03-01 00:00","pubTimestamp":1772294400,"startTime":"0","endTime":"0","summary":"核心观点:哮喘与COPD的异质性决定了2型炎症通路的精准分层与生物标志物驱动的个体化治疗是生物制剂价值兑现的前提;行业呈现“单靶点长效化”与“多靶点协同”的技术迭代趋势,同时COPD异质性催生出PDE3/4吸入制剂与生物制剂并行的双主线格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260301134212a43d2b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02359","BK1583","BK1141","03347","BK1576","06978","02269","BK1574"],"gpt_icon":0},{"id":"2614889463","title":"每日卖空追踪 | 泰格医药 02月27日卖空量成交8.77万股,卖空比例为11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614889463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614889463?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181035,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月27日,跌0.68%,卖空量成交8.77万股,较上一交易日减少70.79%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163502a436797c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1576","BK1141","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":-0.1739},{"period":"3month","weight":-0.0566},{"period":"6month","weight":-0.1191},{"period":"1year","weight":0.1512},{"period":"ytd","weight":-0.0752}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":-0.0652},{"period":"3month","weight":-0.0373},{"period":"6month","weight":-0.0487},{"period":"1year","weight":0.0585},{"period":"ytd","weight":-0.0302}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务,帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务,比如数据管理和统计分析;后勤和执行支持服务,比如临床试验现场管理;行政协助,比如患者招募;以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03226},{"month":2,"riseRate":0.5,"avgChangeRate":0.003406},{"month":3,"riseRate":0.5,"avgChangeRate":-0.040128},{"month":4,"riseRate":0.2,"avgChangeRate":-0.055126},{"month":5,"riseRate":0.4,"avgChangeRate":0.024418},{"month":6,"riseRate":0.6,"avgChangeRate":0.024718},{"month":7,"riseRate":0.6,"avgChangeRate":0.079529},{"month":8,"riseRate":0,"avgChangeRate":-0.091864},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032065},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02594},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001375},{"month":12,"riseRate":0.5,"avgChangeRate":0.041249}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}